7-AAD Viability Staining Solution

Pricing & Availability
Other Names
Viability dye, dead cell exclusion dye, cell viability dye
Ave. Rating
4 reviews
Product Citations
publications
Cat # Size Price Quantity Avail. Save
420403 200 tests 20€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
420404 500 tests 40€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

7-AAD (7-amino-actinomycin D) has a high DNA binding constant and is efficiently excluded by intact cells. It is useful for DNA analysis and dead cell discrimination during flow cytometric analysis. When excited by 488 laser light, 7-AAD fluorescence is detected in the far red range of the spectrum (650 nm long-pass filter).

Product Details
Technical data sheet

Product Details

Formulation
PBS, pH 7.2 with 0.09% (w/v) sodium azide.
Preparation
CAUTION: 7-AAD is a potential carcinogen. It is recommended that the user wear protective clothing, gloves, and eye/face protection in order to avoid contact with skin and eyes.
Concentration
50 µg/ml
Storage & Handling
Protect from light. Store between 2°C and 8°C.
Application

FC - Quality tested

Recommended Usage

For dead cell exclusion, resuspend cell pellet in 0.5 mL of Cell Staining Buffer and add 5 µl of 7-AAD per million cells and incubate for 5-10 minutes in the dark before analysis. The analysis of the cells should be done as soon as possible after the incubation with the dye.

We recommend utilizing our Fluorescence Spectra Analyzer to determine compatibility of 7AAD with other fluorochromes.

 

Excitation Laser
Blue Laser (488 nm)
Application Notes

7-AAD Viability Staining Solution can be used as a viability probe for methods of nonviable cell exclusion.

Additional Product Notes

View more applications data for this product in our Scientific Poster Library.

Application References

(PubMed link indicates BioLegend citation)
  1. Paterson AM, et al. 2011. J. Immunol. 187:1097. PubMed
  2. Wingren M, et al. 2012. Arterioscler Thromb Vasc Biol. 32:2000. PubMed
  3. Sandu SK, et al. 2012. PNAS 109:20047. PubMed
  4. Evdokimova V, et al. 2012. Sci Signal. 5:92. PubMed
  5. Choudhury KR, et al. 2012. PLoS One. 7:e51415. PubMed
  6. Wu Y, et al. 2013. J. Immunol. 190:1859. PubMed
  7. Harker KS, et al. 2013. J. Leukoc Biol. 93:789. PubMed
  8. Zhang ZN, et al. 2013. Clin Chem. 59:1175. PubMed
  9. Mikhak Z, et al. 2013. J Exp Med. 210:1855. PubMed
  10. Cohen HB, et al. 2013. Blood. 122:1935. PubMed
  11. Hufbauer M, et al. 2013. J. Virol. 87:12158. PubMed
  12. Turner JE, et al. 2103. J Exp Med. PubMed
  13. Teng T, et al. 2013. Mol Cell Biol. 33:4660. PubMed
  14. Hussain MS, et al. 2013. Hum Mol Genet. 22:5199. PubMed
  15. Turner JE, et al. 2013 J. Exp Med. 210:2951. PubMed
  16. Kong W, et al. 2014. Cell Immunol. 287:1. PubMed
  17. Fell LH, et al. 2014. Nephrol Dial Transplant. PubMed
  18. Kraaji MD, et al. 2014. Cytokine. 67:7. PubMed
  19. Schneider C, et al. 2014. PNAS. 111:8185. PubMed
  20. Ermann J, et al. 2014. PNAS. 111:2559. PubMed
  21. Cao L, et al. 2014. J Virol. 88:8656. PubMed
  22. Ni PP, et al. 2014. J Immunol. 193:1778. PubMed
  23. Wedel J, et al. 2014. J Leukoc Biol. 96:453. PubMed
  24. Jaworska J, et al. 2015. J Immunol. 194:325. PubMed
Product Citations
  1. Paterson A, et al. 2011. J Immunol. 187:1097. PubMed
  2. Ho J, et al. 2011. PLoS One. 6:e16815. PubMed
  3. Hofmann M, et al. 2012. Leukemia. 26:1288. PubMed
  4. Wigren M, et al. 2012. Arterioscler Thromb Vasc Biol. 32:2000 . PubMed
  5. Sandhu S, et al. 2012. Proc Natl Acad Sci U S A. 109:20047. PubMed
  6. Evdokimova V, et al. 2012. Sci Signal. 5:92. PubMed
  7. Choudhury K, et al. 2012. PLoS One. 7:e51415. PubMed
  8. Wu Y, et al. 2013. J Immunol. 190:1859. PubMed
  9. Harker K, et al. 2013. J Leukoc Biol. 93:789. PubMed
  10. Zhang Z, et al. 2013. Clin Chem. 59:1175. PubMed
  11. Hussain M, et al. 2013. Hum Mol Genet. 22:5199. PubMed
  12. Mikhak Z, et al. 2013. J Exp Med. 210:1855. PubMed
  13. Hussain M, et al. 2013. Hum Mol Genet. 122:1935. PubMed
  14. Hufbauer M, et al. 2013. J Virol. 87:12158. PubMed
  15. Teng T, et al. 2013. Mol Cell Biol. 33:4660. PubMed
  16. Turner J, et al. 2013. J Exp Med. 210:2951. PubMed
  17. Kong W, et al. 2014. Cell Immunol. 287:1. PubMed
  18. Fell L, et al. 2014. Nephrol Dial Transplant. 29:809. PubMed
  19. Kraaij M, et al. 2014. Cytokine. 67:7. PubMed
  20. Schneider C, et al. 2014. Proc Natl Acad Sci U S A. 111:8185. PubMed
  21. Ermann J, et al. 2014. Proc Natl Acad Sci U S A. 111:2559. PubMed
  22. Cao L, et al. 2014. J Virol. 88:8656. PubMed
  23. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  24. Wedel J, et al. 2014. J Leukoc Biol. 96:453. PubMed
  25. Jaworska K, et al. 2015. J Immunol. 194:325. PubMed
  26. Mahiti M, et al. 2015. Biochem Biophys Res Commun. 463: Pags 248-254. PubMed
  27. Bonaccorsi-Riani E, et al. 2015. PLoS One. 10: 0136106. PubMed
  28. Lobb I, et al. 2015. J Urol. In Press, Uncorrected Proof,. PubMed
  29. Schmidt J, et al. 2015. J Immunol Methods. 423: 12-17. PubMed
  30. Otsubo D, et al. 2015. Anticancer Res. 35: 4425-4431. PubMed
  31. Guan H, et al. 2015. Oncogenesis. 4: 166. PubMed
  32. Dokun A, et al. 2015. Am J Physiol Heart Circ Physiol. 309: 790-803. PubMed
  33. Walz S, et al. 2015. Blood. 126: 1203-1213. PubMed
  34. Paterson A, et al. 2015. J Exp Med. 212: 1603-1621. PubMed
  35. Hilliard K, et al. 2015. Infect Immun . 83: 4015 - 4027. PubMed
  36. Urbanska K, et al. 2015. Cancer Immunol Res. 3: 1130 - 1137. PubMed
  37. Leung T, et al. 2015. Genes Dev. 29: 2097 - 2107.. PubMed
  38. Kamimura D, et al. 2015. Int Immunol. 10.1093/intimm/dxv059. PubMed
  39. Campana R, et al. 2015. J Allergy Clin Immunol. pii: S0091-6749(15)01331-7. PubMed
  40. Suarez S, et al. 2015. J Biol Chem. 290: 28311 - 28320. PubMed
  41. Kumai T, et al. 2015. Sci Rep. 5:16280. PubMed
  42. Gebhardt C, et al. 2015. Clin Cancer Res. 21: 5453 - 5459. PubMed
  43. Fuchs R, et al. 2015. Toxicology. 338: 17-29. PubMed
  44. Lee Y, et al. 2016. Am J Physiol Regul Integr Comp Physiol. 310: R55 - R65. PubMed
  45. Ligtenberg M, et al. 2016. J Immunol. 196: 759 - 766. PubMed
  46. Muroski M, et al. 2016. PLoS One. 11: 0145129. PubMed
  47. Palm A, et al. 2016. Sci Rep. 10.1038/srep20531. PubMed
  48. Walachowski S, et al. 2016. PLoS One. 11: 0148464. PubMed
  49. Han W, et al. 2015. Stem Cell Dev. 24: 2536-2546. PubMed
  50. Dingjan I, et al. 2016. Sci Rep. 6:22064. PubMed
  51. Catarinella M, et al. 2016. EMBO Mol Med. 8: 155 - 170. PubMed
  52. Lindgren I, et al. 2016. Hum Reprod. 31: 672 - 683. PubMed
  53. Qi X, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.25. PubMed
  54. Alikhan M, et al. 2016. J Am Soc Nephrol. 27: 706 - 714. PubMed
  55. Eipper S, et al. 2016. PLoS One. 11: 0151509. PubMed
  56. Baker A, et al. 2016. Cancer Res . 76: 1158 - 1169. PubMed
  57. Bosma M, et al. 2016. Nat Commun. 7: 11314. PubMed
  58. Peiris T, et al. 2016. Development. 143: 1697 - 1709.. PubMed
  59. Kadowaki A, et al. 2016. Nat Commun. 7:11639. PubMed
  60. Marsh T, et al. 2016. Cancer Res . 76: 2932 - 2943. PubMed
  61. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  62. Kariminia A, et al. 2016. Blood. 127: 3082 - 3091. PubMed
  63. Quantius J, et al. 2016. PLoS One. 12: 1005544. PubMed
  64. Palm A, Friedrich H, Kleinau S 2016. Sci Rep. 6:27687. PubMed
  65. Ihara S, et al. 2016. J Immunol. 196: 4603 - 4613. PubMed
  66. Urso K, et al. 2016. PLoS One. 11: 0158893. PubMed
  67. Nagafuchi Y, et al. 2016. Sci Rep. 6:29338. PubMed
  68. Coppo M, et al. 2016. Nat Commun. 7:12254. PubMed
  69. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  70. P, et al. 2016. Mol Ther. 24: 1602-1614. PubMed
  71. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  72. Gomez J, et al. 2016. J Immunol. 197: 2864 - 2879. PubMed
  73. Wu X, et al. 2016. Proc Natl Acad Sci U S A. 113(51):14775-14780. PubMed
  74. Perales-Puchalt A, et al. 2017. Clin Cancer Res. 23(2):441-453. PubMed
  75. Chimote A, et al. 2017. Cancer Res . 77(1):53-61. PubMed
  76. Kitazawa M, et al. 2017. PLoS One. 10.1371/journal.pone.0169340. PubMed
  77. Liu S, et al. 2017. PLoS One. 10.1371/journal.pone.0169701. PubMed
  78. McCaw L, et al. 2017. EBioMedicine. 15:24-35. PubMed
  79. Nkwouano V, et al. 2017. PLoS One. 12(2):e0171817. PubMed
  80. Malara A, et al. 2017. J Biol Chem. 292(8):3239-3251. PubMed
  81. Mahauad-Fernandez W, Okeoma C 2017. Cell Death Dis. 10.1038/cddis.2017.68. PubMed
  82. Sogkas G, et al. 2017. Inflammation. 10.1007/s10753-017-0661-y. PubMed
  83. Kurachi M, et al. 2017. Nat Protoc. 10.1038/nprot.2017.083. PubMed
  84. Sun H, et al. 2017. J Autoimmun. 10.1016/j.jaut.2017.08.004. PubMed
  85. Thomas A, et al. 2017. PLoS One.. 10.1371/journal.pone.0183542. PubMed
  86. Kho D, et al. 2017. PLoS One. 10.1371/journal.pone.0180267. PubMed
  87. Naqvi N,et al. 2017. Sci Rep.. 10.1038/s41598-017-12753-1. PubMed
  88. Golubovskaya V,et al. 2017. Cancers (Basel). . 10.3390/cancers9100139. PubMed
  89. Krishnasamy K,et al. 2017. Nat Commun. . 10.1038/s41467-017-00953-2. PubMed
  90. Woolf N, et al. 2017. Oncogenesis. 10.1038/oncsis.2017.77. PubMed
  91. Jacobs R, et al. 2017. J Immunol Methods. . 10.1016/j.jim.2017.09.001. PubMed
  92. Chapelin F, et al. 2017. Sci Rep.. 10.1038/s41598-017-17669-4. PubMed
Publication Library

Antigen Details

Biology Area
Cell Biology, Cell Cycle/DNA Replication, Cell Proliferation and Viability, Neuroscience
Antigen References

1. Schmid I, et al. 1992. Cytometry. 13:204

Gene ID
NA

Related FAQs

Why is washing not recommended after the addition 7-AAD or PI addition when assessing viability?

These dyes bind in equilibrium with DNA. Therefore, external dye concentration must be maintained during analysis and the dye should not be washed out.

Go To Top Version: 2    Revision Date: 05.21.2014

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Login / Register
Forgot your password? Reset password?
Create an Account